GSTM1 and anemia (phenotype): A local study conducted by Bassam et al. regarding treatment patterns in solid cancer patients suggested starting iron supplements before anaemia develops and emphasizing the use of erythropoiesis-stimulating agents (ESAs) when Hb drops below 10 g/dl (21).